A Magnetic Nanoprobe Technology for Detecting Molecular Interactions in Live Cells
- 1 July 2005
- journal article
- retracted article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 309 (5731) , 121-125
- https://doi.org/10.1126/science.1112869
Abstract
Technologies to assess the molecular targets of biomolecules in living cells are lacking. We have developed a technology called magnetism-based interaction capture (MAGIC) that identifies molecular targets on the basis of induced movement of superparamagnetic nanoparticles inside living cells. Efficient intracellular uptake of superparamagnetic nanoparticles (coated with a small molecule of interest) was mediated by a transducible fusogenic peptide. These nanoprobes captured the small molecule's labeled target protein and were translocated in a direction specified by the magnetic field. Use of MAGIC in genome-wide expression screening identified multiple protein targets of a drug. MAGIC was also used to monitor signal-dependent modification and multiple interactions of proteins.Keywords
This publication has 26 references indexed in Scilit:
- Quantum Dots for Live Cells, in Vivo Imaging, and DiagnosticsScience, 2005
- Exploring biology with small organic moleculesNature, 2004
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteinsBiochemical and Biophysical Research Communications, 2004
- Intracellular Delivery of Quantum Dots for Live Cell Labeling and Organelle TrackingAdvanced Materials, 2004
- Transduction peptides: from technology to physiologyNature Cell Biology, 2004
- Endocytosis and SignalingCell, 2003
- From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule ProbesScience, 2003
- Inhibitory effects of tumor necrosis factor-α on cationic lipid-mediated gene delivery to airway cells in vitroBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2001
- Drug target validation and identification of secondary drug target effects using DNA microarraysNature Medicine, 1998